about
An unsupervised MVA method to compare specific regions in human breast tumor tissue samples using ToF-SIMSDoxorubicin in vivo rapidly alters expression and translation of myocardial electron transport chain genes, leads to ATP loss and caspase 3 activationThymoquinone inhibits the CXCL12-induced chemotaxis of multiple myeloma cells and increases their susceptibility to Fas-mediated apoptosisA prognostic gene signature for metastasis-free survival of triple negative breast cancer patientsTranscription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte deathReal time dynamic imaging and current targeted therapies in the war on cancer: a new paradigmReactive oxygen species modulator-1 (Romo1) predicts unfavorable prognosis in colorectal cancer patients.Interpreting Research on Dietary Supplements and Cancer - What is the Take Home Message?Effects of drinking hydrogen-rich water on the quality of life of patients treated with radiotherapy for liver tumorsAnthracycline cardiotoxicity: from bench to bedside.Cellular and molecular mechanisms underlie the anti-tumor activities exerted by Walterinnesia aegyptia venom combined with silica nanoparticles against multiple myeloma cancer cell types.Anthracycline-associated cardiotoxicity in survivors of childhood cancer.Cardiovascular toxicities from systemic breast cancer therapy.The effect of neoadjuvant chemoradiotherapy on whole-body physical fitness and skeletal muscle mitochondrial oxidative phosphorylation in vivo in locally advanced rectal cancer patients--an observational pilot studyAnthracycline cardiotoxicity: prevalence, pathogenesis and treatmentVitamin supplement use during breast cancer treatment and survival: a prospective cohort study.Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?Nutritive Supplements - Help or Harm for Breast Cancer Patients?Caloric restriction mimetic 2-deoxyglucose antagonizes doxorubicin-induced cardiomyocyte death by multiple mechanisms.The effect of radiotherapy and chemotherapy on osmotic fragility of red blood cells and plasma levels of malondialdehyde in patients with breast cancer.Improved antioxidant status by omega-3 fatty acid supplementation in breast cancer patients undergoing chemotherapy: a case series.In Vivo Protective Effects of Diosgenin against Doxorubicin-Induced Cardiotoxicity.Changes in biologic markers of oxidative stress and plasma endotoxin levels in gynecologic cancer patients treated with pelvic radiotherapy: a pilot studyBeta-carotene antioxidant use during radiation therapy and prostate cancer outcome in the Physicians' Health Study.Systematic review: generating evidence-based guidelines on the concurrent use of dietary antioxidants and chemotherapy or radiotherapyOriganum majorana Attenuates Nephrotoxicity of Cisplatin Anticancer Drug through Ameliorating Oxidative Stress.ErbB1/2 tyrosine kinase inhibitor mediates oxidative stress-induced apoptosis in inflammatory breast cancer cells.Thymoquinone synergistically potentiates temozolomide cytotoxicity through the inhibition of autophagy in U87MG cell line.Complementary and alternative medicine: a survey of its use in pediatric oncology.Prevalence and predictors of antioxidant supplement use during breast cancer treatment: the Long Island Breast Cancer Study Project.Emerging paradigms in cardiomyopathies associated with cancer therapies.Cardiomyocyte culture - an update on the in vitro cardiovascular model and future challenges.Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection.Antiapoptotic effect of aminoguanidine on doxorubicin-induced apoptosis.Melatonin-induced methylation of the ABCG2/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cells.Role of hypoxia-inducible factors in the dexrazoxane-mediated protection of cardiomyocytes from doxorubicin-induced toxicity.Protective effect of Lycium barbarum on doxorubicin-induced cardiotoxicity.Impact of chemotherapy on symptom profile, oxidant-antioxidant balance and nutritional status in non-small cell Lung Cancer.Effects of acute doxorubicin treatment on hepatic proteome lysine acetylation status and the apoptotic environment.Vitamin e and N-acetylcysteine as antioxidant adjuvant therapy in children with acute lymphoblastic leukemia.
P2860
Q27334982-2DAC0A3A-2CCF-42E6-9E4C-15278DE89FA7Q28383334-25502B1C-7F7E-41A2-930B-8797EF899A06Q28476755-C203297A-6F56-46D2-9005-F4927796A012Q28536791-8D3DBADA-80A3-4816-BBC0-0AC20DED55F6Q28579471-B512C3C5-9CAC-447A-9DC3-61959FB47CA7Q30453423-ED2D8F88-CFFF-404D-92E4-B69C76F10F72Q33637755-3E5FBDBB-2658-4295-8B94-2436941967E8Q34206038-FF05AAF4-16EC-4F99-8E49-317B874CE8EDQ34238732-08A724AF-939C-4D4A-BE51-7CA8467768DEQ34477415-F4F97838-D29D-4026-9DF1-698B7991499BQ34517100-F885A598-1771-4BD4-813B-4B1BFCF7EF19Q34626238-81740D2B-F187-4B29-A9AA-1718DF97CE76Q34630349-DA499F21-1963-4495-9C56-3313735529FBQ34639381-CCEDCEA6-D157-41F7-ADF5-D7552AF458A2Q34639876-A6E584C0-EEA8-4C46-A74D-5A91AD0D5356Q34669900-35FCB3C3-7273-4342-97DF-EE6886B64D44Q34782021-0ED0D44F-31E8-4445-83CC-E73449623313Q34791119-D5943668-5BD2-4578-86F2-57534D1FD81CQ35063002-526CFA9C-8205-456F-85E0-E02F81763A8FQ35768829-5534BD00-405A-4575-92B1-C121948195B4Q35800403-6503ADA5-B78B-4DEC-8919-EA94BF8BAEE6Q35809052-E60F1D62-18B3-4A0A-BA6F-1696CFD2B9A0Q35886056-2E0EFB86-BCAF-4B86-87FF-75BC215CB1C3Q36067653-B88E4F4B-1E4D-4025-86C1-22377C50FE34Q36883705-7D2AB5C5-B712-4069-A05E-208AF24C9269Q36941751-9353F6E6-B9B7-4FDA-8F02-B2E88188697CQ37072265-FB4AA4B1-344A-433B-87B5-BB1524F4BB3FQ37306947-E71AB836-A9F5-4069-A2A3-230E38B26831Q37331785-8694797B-E2D5-40FA-8B95-BDC962596455Q37390895-1F892E8E-F8FF-4890-9A6F-2BCB2E81BD2DQ38132645-E66799BD-AAE3-4322-9783-D091FBE831B3Q38167330-BBA10E68-2608-439B-900A-149FB4849500Q38546114-DC00362F-A5F7-479C-A31C-32CDE601FB79Q38993911-B3366E1E-95BD-4B52-9B09-FCBB516D2392Q39158092-F63CA3BE-36A3-4684-A3C5-48F4A4CB36D7Q39608341-C3D5BE02-13E9-445D-946B-A0C2DD4129EEQ40108911-C28DE60C-F57D-4C38-93BB-0C097C3B27C7Q40979315-35DD57EB-61D8-47BA-8E1F-4674D8B97A91Q41906465-53F626D6-309B-4894-9FC4-D185779D97F9Q42641741-6EB49FAB-FBA2-4999-9B8A-9F832E6BC3D8
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Antioxidants and cancer therapy: a systematic review.
@ast
Antioxidants and cancer therapy: a systematic review.
@en
type
label
Antioxidants and cancer therapy: a systematic review.
@ast
Antioxidants and cancer therapy: a systematic review.
@en
prefLabel
Antioxidants and cancer therapy: a systematic review.
@ast
Antioxidants and cancer therapy: a systematic review.
@en
P2093
P356
P1476
Antioxidants and cancer therapy: a systematic review.
@en
P2093
Aaron Fleischauer
Deborah D Kennedy
Elena J Ladas
Judith S Jacobson
Kara M Kelly
Katherine Teel
P304
P356
10.1200/JCO.2004.03.086
P407
P577
2004-02-01T00:00:00Z